Emily Lythell - November 21, 2024

Resistance is futile – how new tech tackles AMR

Antimicrobial resistance (AMR) refers to the ability of microorganisms—bacteria, viruses, fungi, ...

Andy Newland - November 21, 2024

Mewburn Ellis wins the NetDocuments Inspire Customer Automation Award

Mewburn Ellis is proud to announce that we have been awarded the prestigious NetDocuments Inspire ...

Matthew Naylor - November 18, 2024

UPC Weekly - UPC dials up the advantages for patentees

2024 Week 46 We report this week on two new UPC decisions that make the UPC an even more attractive ...

Darena Slavova - November 15, 2024

Commercialising IP to fuel the fusion revolution

The race for fusion energy is on, but it’s not a sprint. Fusion energy is not expected to enter the ...

Eliot Ward - November 13, 2024

Cambiotics: a novel treatment for PFAS ‘forever chemicals’

PFAS are toxic pollutants causing health problems globally. There is currently no treatment. Now a ...

Maria Hall - November 13, 2024

Mewburn Ellis is the world’s first IP firm to be awarded an EcoVadis Platinum Medal

European intellectual property firm Mewburn Ellis has achieved a significant milestone by earning ...

Alex Savin - November 12, 2024

‘Small’ Nuclear – the solution for Big Data?

The growth of AI is set to explode data centre power demand by the end of the decade, according to ...

Matthew Naylor - November 11, 2024

UPC Weekly - NJOY duel with Juul

2024 Week 45 5 November 2024 saw two decisions handed down by the UPC Paris Central Division (CD) ...